The research and development of AttentiveCare has been sponsored in large part by the National Institutes of Health's (NIH) National Institute on Aging (NIA). Two research and development projects sponsored by NIA have focused on the use of Internet-based technology to provide informal care for persons with Alzheimer's Disease. A Phase I Feasibility Study was completed in 2004 and an extended Phase II Study is currently underway. Although the research and development has focused on persons with Alzheimer's Disease, the technology can be used to provide care to older adults or persons with other chronic conditions and disabilities.
NIH Phase II Study (Current Study): This study is a two-year research and development project sponsored by the NIA. The research focuses on that application of AttentiveCare for caregivers of persons with Alzheimer's Disease. The study began on July 1, 2005 and will go through June 30, 2007. This is the extension of a Phase I Study completed in 2004.
The study will evaluate the use of AttentiveCare in a variety of caregiving situations: care receivers who live alone and are supported by a remote or long-distance caregivers, care receivers who live with a resident caregiver and have a remote or long-distance secondary caregiver, and care receivers who live with a resident caregiver who works either full-time or part-time. The study will evaluate all aspects of AttentiveCare: software, services, and caregiver usage and benefits. Data collected from the caregiver will permit the subjective and quantitative analysis and assessment of the caregiver usage and benefits of AttentiveCare.
Participants in the study are caregivers of persons diagnosed with early - to moderate stage Alzheimer's Disease. The care receiver may live alone or with a resident caregiver in a private residence or an independent living center or they may reside in an assisted living center. The study will include installing a personal computer with a video camera in the home or living environment of the care receiver. For more information regarding the Study, Contact Us - NIH Field Test.